Detection and Genotyping of Human Papillomavirus in Hypopharyngeal Carcinoma Samples

Akoglu, H. (2018). User’s guide to correlation coefficients. Turkish J. Emerg. Med.,18, 91–93.10.1016/j.tjem.2018.08.001610796930191186Search in Google Scholar

Anonymous (2007). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 90. Human Papillomaviruses. International Agency for Research on Cancer, Lyon. 689 pp.Search in Google Scholar

Baasland, I., Romundstad, P. R., Eide, M. L., Jonassen, C. M. (2019). Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population. PLoS ONE, 14 (1), e0210997.10.1371/journal.pone.0210997634390930673759Search in Google Scholar

Combes, J.-D., Franceschi, S. (2014). Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol.,50, 370–379.10.1016/j.oraloncology.2013.11.00424331868Search in Google Scholar

Cornall, A. M., Poljak, M., Garland, S. M., Phillips, S., Machalek, D. A., Tan, J. H., Quinn, M. A., Tabrizi, S. N. (2017). HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples. Papillomavirus Res.,4, 79–84.10.1016/j.pvr.2017.10.002588323629179874Search in Google Scholar

Dahm, V., Haitel, A., Kaider, A., Stanisz, I., Beer, A., Lill, C. (2018). Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas. Eur. Arch. Oto-Rhino-Laryngol.,275, 1837–1843.10.1007/s00405-018-4997-1599223729744637Search in Google Scholar

Dayyani, F., Etzel, C.J., Liu, M., Ho, C.-H., Lippman, S. M., Tsao, A. S. (2010). Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol.,2, 15.10.1186/1758-3284-2-15290808120587061Search in Google Scholar

Del Pino, M., Alonso, I., Rodriguez-Trujillo, A., Bernal, S., Geraets, D., Guimerą, N., Torne, A., Ordi, J. (2017). Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection. J. Virol. Meth.,248, 238–243.10.1016/j.jviromet.2017.07.00928739302Search in Google Scholar

Gillison, M. L., Castellsagué, X., Chaturvedi, A., Goodman, M. T., Snijders, P., Tommasino, M., Arbyn, M., Franceschi, S. (2014). Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int. J. Cancer,134, 497–507.10.1002/ijc.2820123568556Search in Google Scholar

Gillison, M. L., Chaturvedi, A. K., Anderson, W. F., Fakhry, C. (2015). Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma. J. Clin. Oncol.,33, 3235–3242.10.1200/JCO.2015.61.6995497908626351338Search in Google Scholar

Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., Sidransky, D. (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst.,92, 709–720.10.1093/jnci/92.9.70910793107Search in Google Scholar

Gillison, M. L., Shah, K. V. (2001). Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr. Opin. Oncol.,13, 183–188.10.1097/00001622-200105000-00009Search in Google Scholar

Lillsunde Larsson, G., Carlsson, J., Karlsson, M. G., Helenius, G. (2015). Evaluation of HPV genotyping assays for archival clinical aamples. J. Mol. Diagn.,17, 293–301.10.1016/j.jmoldx.2014.12.004Search in Google Scholar

Ludyga, N., Grünwald, B., Azimzadeh, O., Englert, S., Höfler, H., Tapio, S., Aubele, M. (2012). Nucleic acids from long-term preserved FFPE tissues are suitable for downstream analyses. Virchows Archiv.,460, 131–140.10.1007/s00428-011-1184-9Search in Google Scholar

de Martel, C., Plummer, M., Vignat, J., Franceschi, S. (2017). Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer,141, 664–670.10.1002/ijc.30716Search in Google Scholar

Mukaka, M. (2012). A guide to appropriate use of correlation coefficient in medical research. Malawi Med. J.,24, 69–71.Search in Google Scholar

Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., Franceschi, S. (2016). Global burden of cancers attributable to infections in 2012: A synthetic analysis. The Lancet. Global Health,4, e609–616.10.1016/S2214-109X(16)30143-7Search in Google Scholar

Şahiner, F., Kubar, A., Gümral, R., Ardıç, M., Yiğit, N., Şener, K., Dede, M., Yapar, M. (2014). Efficiency of MY09/11 consensus PCR in the detection of multiple HPV infections. Diagn. Microbiol. Infect. Dis.,80, 43–49.10.1016/j.diagmicrobio.2014.03.030Search in Google Scholar

Shield, K. D., Ferlay, J., Jemal, A., Sankaranarayanan, R., Chaturvedi, A. K., Bray, F., Soerjomataram, I. (2017). The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. Cancer J. Clin.,67, 51–64.10.3322/caac.21384Search in Google Scholar

Shikova, E., Todorova, I., Ganchev, G., Kouseva-Dragneva, V. (2009). Detection and typing of human papillomaviruses by PCR. Biotechnol. Biotechnol. Equip.,23, 877–880.10.1080/13102818.2009.10818562Search in Google Scholar

Srinivasan, M., Sedmak, D., Jewell, S. (2002). Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Amer. J. Pathol.,161, 1961–1971.10.1016/S0002-9440(10)64472-0Search in Google Scholar

Vandamme, A.-M., Fransen, K., Debaisieux, L., Marissens, D., Sprecher, S., Vaira, D., Vandenbroucke, A. T., Verhofstede, C., Van Dooren, S., Goubau, P. et al. (1995). Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. J. Virol. Meth.,51, 305–316.10.1016/0166-0934(94)00126-2Search in Google Scholar

Veyer, D., Wack, M., Grard, O., Bonfils, P., Hans, S., Belec, L., Badoual, C., Péré, H. (2019). HPV detection and genotyping of FFPE head and neck cancer biopsies by molecular testing to address new oropharyngeal squamous cell carcinoma classification based on HPV status. Pathology, 51 (4), 421–425.10.1016/j.pathol.2019.02.002Search in Google Scholar